BIOTECHNOLOGY

Ellume, the digital diagnostics company helping people beat the flu

Finfeed Archived Apr 12, 2019

Dr Sean Parsons is the founder of Ellume, an emerging digital diagnostics company situated in Brisbane that provides smart, self-use diagnostics for the detection and management of pandemic influenza.

Immuron seeking FDA approval for travelers’ diarrhea drug candidate

Finfeed Archived Apr 11, 2019

Australian biopharmaceutical company, Immuron Limited (ASX: IMC |NASDAQ: IMRN), plans to pursue clinical development of IMM-124E, its bovine polyclonal antibody drug candidate to prevent travelers’ diarrhea, through a formal FDA registration pathway.

Genetic Technologies teams up with TGen

Finfeed Archived Apr 08, 2019

Genetic Technologies Ltd (ASX:GTG), a provider of world-leading genetic risk assessment test products, has established an important MoU with TGen, a major player in the US biomedical research industry.

Imugene to present cancer vaccine programs to the American Association for Cancer Research

Finfeed Archived Mar 04, 2019

Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced Dr Tanios Bekaii-Saab from the Mayo Clinic will present on its KEYVaxx and B-Vaxx cancer vaccine programs at the American Association for Cancer Research (AACR) 2019 Annual Meeting.

Cashed up Imugene to present at American Association for Cancer Research

Finfeed Archived Feb 28, 2019

Clinical stage immuno-oncology company, Imugene Limited (ASX:IMU), is developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors.

One emerging industry could be the next investment opportunity

Finfeed Archived Feb 19, 2019

Global biotech company Zoono Group Limited (ASX:ZNO) Founder and CEO Paul Hyslop is an expert on long lasting antimicrobial protection and outlines the industry opportunity to The Capital Network’s Executive Director Lelde Smits.

Hemp demand sees Elixinol fly high with outstanding revenue growth

Finfeed Archived Feb 19, 2019

Shares in Elixinol Global Ltd (ASX:EXL; OTCQX:ELLXF) have surged in February after the company announced outstanding year-on-year revenue growth for both the December quarter and calendar year 2018.

PTX is one step closer to finding a working cancer treatment

Finfeed Archived Jan 29, 2019

Prescient Therapeutics (ASX:PTX) CEO Steven Yatomi-Clarke speaks with Finfeed about the latest results in the company's cancer treatment trials.

I’m dreaming of a genome Christmas